Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc         Stock Exchange Release    9 April 2021 at 11.00, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from OP-Rahastoyhtiö Oy (“OP-Rahastoyhtiö”). According to the notification, the total holdings in Optomed shares and votes held by OP-Rahastoyhtiö has increased to 5.46 per cent of all of the registered shares in Optomed on 8 April 2021.

Ropo Capital completes acquisition of Norwegian company BAHS Kapital AS

Ropo Capital has completed the acquisition of the entire share capital of BAHS Kapital AS, as announced on 10 March 2020 . With the acquisition, BAHS Kapital has become part of the Ropo Capital Group. In acquiring the company, Ropo Capital continues its growth in the Nordic countries and speeds up the launch of its automation-based invoice lifecycle service in the Norwegian market. The goal of the company is to become the Nordic market

DecideAct enters new field and signs contract with first incubator.

DecideAct has today signed a contract with the first customer in the incubator field, Market Leader in France. Market Leader helps, guides and develops French startups to become viable companies and will be using the DecideAct solution to deploy strategic governance over the startup growth cycle.DecideAct A/S [ACT] Company Announcement No. 11-2021: About DecideAct A/S [ACT]   We are pleased to announce that DecideAct now enters a new business category and has signed with the first incubator as we are welcoming Market Leader in France as a DecideAct customer. Market Leader is

Fully recruited clinical trial in LADA with Diamyd®

The clinical Phase II trial GADinLADA, where the diabetes vaccine Diamyd[®] is administered directly into the lymph node in patients with the autoimmune form of diabetes LADA (Latent Autoimmune Diabetes in Adults), is fully recruited, and the first results from the trial are planned to be announced in early 2022.The first analysis of clinical and immunological parameters will be performed when all patients have been followed for 5 months after their first injection, which means that the results are expected to be presented at the beginning of next year. The patients will be followed for a

TOMRA appointed as reverse vending technology provider for new Latvia deposit return system

TOMRA wins today tender for reverse vending machines for the return of bottles and cans across the country in 2022.   SIA Depozīta Iepakojuma Operators, the future central system administrator for the deposit return system (DRS) in Latvia, today announced that TOMRA has won the tender to provide the reverse vending technology for the upcoming bottle and can recycling program. A negotiation period will follow with the contract set to be signed by July 1, 2021. TOMRA will supply approximately 800 automated collection points, combining around 625 indoor reverse vending solutions and

Capital increase in TORM in connection with delivery of vessel

With reference to Company Announcement no. 03 dated 01 March 2021 regarding the acquisition of eight 2007-2012 built MR product tanker vessels from TEAM Tankers Deep Sea Ltd, TORM plc (“TORM”) has increased its share capital by 877,128 A-shares (corresponding to USD 8,771.28) as a result of the delivery of the first vessel of the transaction, the MR vessel TEAM Corrido. The capital increase is carried out without any pre-emption rights for existing shareholders or others. The new shares have been subscribed for due to the settlement of a USD 8.1m allocated loan note issued in connection

Yaytrade has entered into sales agreements on samples and overstock items with new customers

Ytrade Group AB (publ) (“Yaytrade” or “the Company”) has in just a short time taken a strong position in digital sales of samples and overstock items for premium fashion companies in Sweden. At the end of March, the company entered into new agreements with Ahlvar Gallery from Sweden and Ril’s from Finland with estimated volume of 1,500 items added to the pipeline.In addition to the influx of items from these new deals with Ahlvar Gallery and Ril’s, Yaytrade has seen very large positive outcomes from the company’s latest sales with J.Lindeberg, Hope, Flattered, and Sandqvist. "Yaytrade

NCC to construct Granåsen sports facility on behalf of Trondheim Municipality

NCC and Trondheim Municipality have signed an agreement to construct the new Granåsen winter sport venue in Trondheim, Norway. The project has been optimized in an initial phase during which the parties worked together to devise suitable technical solutions and plans for the implementation phase. The order is worth approximately SEK 470 million. Illustration: Pir II The project consists of extensions, improvements and new construction by both ski jumping hills, a new shooting range, a new ski bridge, a new judge tower, new grandstands, a new arena with a shooting range integrated

Notice to annual general meeting in ITAB Shop Concept AB (publ)

The shareholders in ITAB Shop Concept AB (publ), Reg.No. 556292-1089, with its registered office in Jönköping county, Sweden, are hereby summoned to the annual general meeting to be held on Tuesday 11 May 2021.Due to the extraordinary situation resulting from the covid-19 pandemic, the annual general meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. A pre-recorded presentation with the CEO, Andréas Elgaard, will be published on the

Stena Livia joins the Baltic Sea fleet

Stena Line today announce the latest addition to their Baltic Sea fleet. The 186 metre long Visentini RoPax vessel Stena Livia will initially join sister vessel Stena Flavia on the Nynäshamn-Ventspils route from mid-April. Later this year the pair will replace the existing tonnage on the ferry route between Travemünde and Liepaja, adding 40 per cent freight capacity and shorten the crossing time substantially.During 2021 Stena Line is expanding their Baltic Sea operations with modern and large RoPax vessels being added to the two ferry routes from Latvia to Sweden and Germany. The routes,

Stena Livia joins the Baltic Sea fleet

Stena Line/Stena Rederi A/S today announce the latest addition to their Baltic Sea fleet. The 186 metre long Visentini RoPax vessel Stena Livia will initially join sister vessel Stena Flavia on the Nynäshamn-Ventspils route from mid-April. Later this year the pair will replace the existing tonnage on the ferry route between Travemünde and Liepaja, adding 40 per cent freight capacity and shorten the crossing time substantially.During 2021 Stena Line is expanding their Baltic Sea operations with modern and large RoPax vessels being added to the two ferry routes from Latvia to Sweden and

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS ALPHA

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value of Proventus Capital Partners Alpha participation loan amounted to SEK 807,380 per debenture. Ordinary income of SEK 22,080 per debenture will be distributed to debenture holders on 16 April 2021. A partial repayment of the participation loan debentures amounting to SEK 55,000 per debenture will be made on 30 April 2021 Proventus Capital Partners Alpha’s assets are composed of 100 per cent privately issued corporate loans. During the quarter one private loan was fully

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS III

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value per participation loan debentures of Proventus Capital Partners III, was SEK 347,938 for series A and SEK 8,701,679 for series B. Ordinary income of SEK 6,949 per series A participation loan debenture and SEK 176,947 per series B participation loan debenture will be distributed on 16 April 2021. A partial repayment will be made on 30 April 2021 amounting to SEK 9,000 per series A debenture and SEK 225,000 per series B debenture. Proventus Capital Partners III’s assets are

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value, per participation loan debentures of Proventus Capital Partners IV, is EUR 104.25 for series A1. Ordinary Income of EUR 2.28 per series A1 participation loan debentures will be distributed to debenture holders on 23 April 2021. No repayment of capital will be distributed to debenture holders for the quarter. Proventus Capital Partners IV’s assets are composed of 97.1 per cent privately issued corporate loans and 2.9 per cent publicly traded corporate bonds. P Capital is

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV B

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value per participation loan debentures of Proventus Capital Partners IV B, is EUR 103.44 for series A1 and EUR 1,035.59 for series B. Ordinary Income of EUR 1.86 per series A1 participation loan debentures and EUR 19.78 per series B participation loan debenture will be distributed on 23 April 2021. No repayment of capital will be distributed to debenture holders for the quarter. Proventus Capital Partners IV B’s assets are composed of 97.1 per cent private high-yield loans and 2.

Invitation to conference call and webcast presentation of Dometic’s interim report for the first quarter 2021

Dometic Group AB (publ) will publish its interim report for the first quarter 2021 at around 08.00 CEST on Friday, April 23, 2021. On the same day at 10.00 CEST, Dometic will host a conference call and webcast to present the results. The presentation can be followed live via webcast and will also be available afterwards. The presentation will be held in English. The report and the presentation material will be available on Dometic’s website, www.dometic.com/ir Webcast link: https://onlinexperiences.com/Launch/QReg/ShowUUID=EB712CA3-72F4-41E1-806D-7697477BAE1F 

SciBase publishes the Annual report for 2020

SciBase hereby announces that the Annual report for 2020 is available at the Company’s website www.scibase.com.A pdf-version of the annual report is enclosed to this press-release.A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy.For more information, please contact: Michael Colérus, CFO Tel: +46 70 341 34 72 E-mail: michael.colerus@scibase.com Certified Advisor Avanza Tel: +46 8 409 421 20 E-mail: ca@avanza.se The information was submitted for publication, through the agency of the contact person

Probi publishes Annual Report for 2020

Probi's Annual Report and Sustainability Report for 2020 are now available on the company website, www.probi.com under Investor Relations: https://www.probi.com/investor-relations/financial-reports/   This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 9.00 CET on 9 April 2021. For further information, please contact: Henrik Lundkvist, CFO, Phone +46 46 286 89 41, E-mail: henrik.lundkvist@probi.com   ABOUT PROBI Probi[®] is a global company focused exclusively on

Invitation to SSAB’s report for the first quarter of 2021

SSAB invites you to a presentation of the report for the first quarter of 2021 at 9.30am CEST on Monday, April 26, 2021. The briefing will take place by conference call that will also be webcast on SSAB’s website. The report will be published at approximately 7.30am CEST on the same date.The report for the first quarter of 2021 will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Håkan Folin. The briefing will be held in English. Time of briefing: Monday, April 26, 2021 at 9.30am CEST. Teleconference numbers:Sweden:                        +46 856 6426 51United

Invitation to Investor Meeting April 29, 2021

Welcome to MSAB's digital investment meeting on April 29 at 9:00 - 10:30, in connection with the financial reporting of the first quarter of 2021. During the presentation, you will get a more detailed description of MSAB as a company. The goal is to provide a wider and deeper understanding of the company, the business model, markets, and how MSAB sees the future of mobile forensics. Agenda: - Introduction of MSAB - Strategy & Opportunities - Innovations - Markets & Customers - Financial goals and investment management - Wrap up & discussion Register to the webinar

BioStock: BiBBInstruments submits third international patent application

On Thursday, BiBBInstruments announced that the company has filed another international patent application regarding EndoDrill Model X, an electric biopsy instrument for endoscopic use that will contribute to earlier cancer diagnoses. The company has so far applied for a total of three patents for EndoDrill Model X, and with this application the company intends to further strengthen the patent protection for the product.Read the full article at biostock.se: https://www.biostock.se/en/bibbinstruments-submits-third-international-patent-application/ This is a press release from BioStock -

Annual Report from Cyxone AB for the period 1 January 2020 to 31 December 2020

Cyxone AB’s Annual Report for the financial year 2020 is now available at the company’s website (www.cyxone.com).Please see attached Annual Report as pdf. Contact Tara Heitner, CEOTel: +46 70 781 88 08Email: tara.heitner@cyxone.comAdelgatan 21211 22 Malmö, Sweden About Cyxone Cyxone AB (publ) (Nasdaq First North Growth Market: CYXO) develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders. Rabeximod is a Phase 2 candidate drug being evaluated for the

Invitation to presentation of NOTE´s Interim Report on 19 April

The Interim Report for the first quarter 2021 will be published 19 April at 8:30 a.m. CET. The same day, at 10:00 a.m. CET, NOTE will arrange a teleconference for analysts, media and investors. The report will be presented by NOTE’s CEO and President Johannes Lind-Widestam. The presentation will be held in English. To join the meeting, paste this link in your browser. If you have a problem connecting, try another browser. https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODY3MmIwNjQtNmExNC00MDEzLThjYzgtMjZiNzdmOTExMWI2%40thread.v2/0?context=%7b%22Tid%22%3a%22343c6c80-6b68-4f74-

There are no items matching the current filter
There are no more items matching the current filter
Back to top